Why Choosing Limb Salvage Over Amputation is a Lifesaving Decision

The choice of treatment for severe Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) has profound consequences, not only for a patient's quality of life but also for their long-term survival. A significant body of research demonstrates that minor, limb-salvage procedures like a Transmetatarsal Amputation (TMA) offer a major advantage in life expectancy over major amputations like a Below-Knee Amputation (BKA).

The Survival Advantage of Limb Salvage

A retrospective review of patients who underwent TMA found a dramatic difference in long-term mortality rates when compared to more proximal (higher-level) amputations:

• TMA Five-Year Mortality Rate: The study found a 39% mortality rate five years after a TMA procedure.

  
  

• BKA Five-Year Mortality Rate: This is significantly lower than the documented five-year mortality rate for BKA, which is reported to range from 40% to 82%.

  
  

• Increased Longevity: This evidence supports the concept that minor limb amputation, such as a TMA, increases patient longevity compared to major amputations.

  
  

• Early Mortality Risk: Even in the first year, 33% of deceased TMA patients passed away within the first 12 months after the procedure, highlighting the fragility of this patient population.

  
  

The Impact of Co-Morbidities

Survival rates after lower extremity amputation are strongly associated with underlying co-morbidities. The study of TMA patients revealed a high prevalence of serious health issues:

• Hypertension (HTN): 89.9% of patients.

  
  

• Diabetes: 79.1% of patients.

  
  

• Peripheral Vascular Disease (PVD): 52.7% of patients.

  
  

The Elevated Risk of Renal Disease

A particularly alarming finding was the severe impact of renal disease on patient survival:

• Higher Mortality: Mortality in patients with renal disease was higher compared to other diseases.

  
  

• Deceased Patients: Of the deceased patients, 57% suffered from renal diseases.

  
  

• Overall Prevalence: Renal disease was present in 45% of all patients in the study.

  
  

Why This Matters

The decision to choose a more distal, limb-sparing procedure (like a TMA) is vital. A more proximal amputation carries a greater risk of unfavorable outcomes, including a decreased life span. Surgeons must consider the decrease in life span associated with a more proximal amputation when making surgical decisions for patients with extensive co-morbidities.

If you fall into any of these categories, talk to your primary care provider about being screened for PAD. Early detection and intervention are critical to preserving your limbs and extending your life.

(918) 943-5303 | www.tulsacardiovascularcenter.com